missing translation for 'onlineSavingsMsg'
Learn More
Learn More
CB 300919, MedChemExpress
Description
CB 300919 is a quinazoline-based antitumour agent with high activity in the CH1 human ovarian tumour xenograft. CB 300919 has a continuous exposure (96 h) growth inhibition IC50 value of 2 nM in human CH1 ovarian tumor xenograft.
Specifications
Specifications
| Chemical Name or Material | CB 300919 |
| Physical Form | Solid |
| CAS | 289715-28-2 |
| Color | Off-White |
| Quantity | 5 mg |
| Purity Grade Notes | Research |
| Molecular Formula | C32H34ClN7O2 |
| For Use With (Application) | Cancer-programmed cell death |
| Solubility Information | DMSO : ≥ 100 mg/mL (171.20 mM) ∣H2O : < 0.1 mg/mL (insoluble) |
| SMILES | CN1CCN(CC1)CC2=NC3=C(C(N2C)=O)C=C(CN(CC#C)C4=CC=C(C=C4)C(NCC5=CC=CN=C5)=O)C(Cl)=C3 |
| Show More |
Research purposes only
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?